Total Payments
$8,624
2024 Payments
$927.27
Companies
22
Transactions
303
Medicare Patients
11,551
Medicare Billing
$993,230
Payment Breakdown by Category
Food & Beverage$5,931 (68.8%)
Travel$2,625 (30.4%)
Other$68.20 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,931 | 293 | 68.8% |
| Travel and Lodging | $2,625 | 9 | 30.4% |
| Debt forgiveness | $68.20 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $3,094 | 62 | $0 (2020) |
| Boston Scientific Corporation | $2,621 | 74 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $594.77 | 40 | $0 (2024) |
| Abbott Laboratories | $554.75 | 17 | $0 (2024) |
| Medtronic, Inc. | $532.61 | 49 | $0 (2024) |
| PFIZER INC. | $272.93 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $169.23 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $137.12 | 9 | $0 (2024) |
| Shockwave Medical, Inc | $103.70 | 4 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $98.22 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $927.27 | 49 | Novartis Pharmaceuticals Corporation ($179.72) |
| 2023 | $777.79 | 37 | Boston Scientific Corporation ($210.57) |
| 2022 | $996.24 | 54 | Boston Scientific Corporation ($315.53) |
| 2021 | $587.32 | 41 | Medtronic, Inc. ($236.34) |
| 2020 | $1,478 | 27 | Medtronic Vascular, Inc. ($1,311) |
| 2019 | $208.69 | 8 | Boston Scientific Corporation ($94.67) |
| 2018 | $2,008 | 57 | Boston Scientific Corporation ($1,364) |
| 2017 | $1,641 | 30 | Medtronic Vascular, Inc. ($1,310) |
All Payment Transactions
303 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Boston Scientific Corporation | RESONATE EL ICD VR (Device) | Food and Beverage | In-kind items and services | $30.52 | General |
| Category: RESONATE_CRM | ||||||
| 11/19/2024 | Boston Scientific Corporation | ACCOLADE SR (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: ACCOLADE_CRM | ||||||
| 11/15/2024 | Boston Scientific Corporation | INGEVITY+ (Device) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: Ingevity+_CRM | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $36.04 | General |
| Category: Pacemakers | ||||||
| 11/04/2024 | Abbott Laboratories | TENDRIL (Device) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: Cardiovascular | ||||||
| 10/18/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | Boston Scientific Corporation | INGEVITY+ (Device) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Ingevity+_CRM | ||||||
| 08/31/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: DIABETES | ||||||
| 07/09/2024 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: EMBLEM_CRM | ||||||
| 07/03/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Structural Heart | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 2,685 | 3,887 | $805,892 | $224,995 |
| 2022 | 39 | 3,077 | 4,147 | $937,633 | $283,276 |
| 2021 | 36 | 3,045 | 4,248 | $934,708 | $285,529 |
| 2020 | 37 | 2,744 | 3,871 | $722,706 | $199,429 |
Total Patients
11,551
Total Services
16,153
Medicare Billing
$993,230
Procedure Codes
167
All Medicare Procedures & Services
167 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 355 | 356 | $194,020 | $47,008 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 310 | 341 | $68,200 | $29,070 | 42.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 181 | 406 | $71,050 | $24,404 | 34.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 140 | 158 | $51,350 | $15,038 | 29.3% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 18 | 18 | $42,390 | $12,718 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 188 | 194 | $24,250 | $11,402 | 47.0% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 20 | 20 | $41,100 | $7,537 | 18.3% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 19 | 19 | $25,745 | $7,537 | 29.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 115 | 148 | $22,480 | $7,178 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $17,875 | $6,694 | 37.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 158 | 392 | $33,320 | $5,522 | 16.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 102 | 251 | $22,590 | $4,853 | 21.5% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 22 | 22 | $8,052 | $4,353 | 54.1% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 28 | 165 | $18,150 | $4,241 | 23.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 74 | 75 | $13,125 | $3,987 | 30.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 43 | 43 | $13,115 | $3,472 | 26.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 61 | 140 | $23,800 | $3,117 | 13.1% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 32 | 45 | $10,600 | $3,021 | 28.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 28 | 163 | $11,410 | $2,992 | 26.2% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 35 | 41 | $8,610 | $2,872 | 33.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 223 | 246 | $18,450 | $2,418 | 13.1% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 22 | 28 | $8,540 | $2,270 | 26.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 27 | 28 | $9,100 | $1,689 | 18.6% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 17 | 20 | $6,000 | $1,410 | 23.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 13 | $2,925 | $1,211 | 41.4% |
About Dr. Matthew Stopper, MD
Dr. Matthew Stopper, MD is a Cardiovascular Disease healthcare provider based in Scranton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659467330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Stopper, MD has received a total of $8,624 in payments from pharmaceutical and medical device companies, with $927.27 received in 2024. These payments were reported across 303 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,931).
As a Medicare-enrolled provider, Stopper has provided services to 11,551 Medicare beneficiaries, totaling 16,153 services with total Medicare billing of $993,230. Data is available for 4 years (2020–2023), covering 167 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Scranton, PA
- Active Since 10/04/2006
- Last Updated 04/19/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1659467330
Products in Payments
- Arctic Front (Device) $1,305
- Micra (Device) $1,107
- WATCHMAN (Device) $1,023
- Resolute (Device) $452.44
- ENTRESTO (Drug) $424.28
- ELIQUIS (Drug) $375.62
- Rhythmia Mapping System (Device) $194.86
- RESOLUTE ONYX (Device) $183.06
- RESONATE (Device) $176.08
- LEQVIO (Drug) $170.49
- XARELTO (Drug) $169.23
- EMBLEM MRI S-ICD (Device) $119.76
- CoreValve Evolut (Device) $119.15
- GENERAL STENTS (Device) $113.68
- Xience Sierra Coronary Stent (Device) $110.38
- LUX-Dx Insertable Cardiac Monitor (Device) $106.82
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $103.70
- RESONATE EL ICD VR (Device) $99.72
- JARDIANCE (Drug) $98.22
- RHYTHMIA MAPPING SYSTEM (Device) $97.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Scranton
Dr. Nishant Sethi, M.d, M.D
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Dr. Thomas Roe, M.d, M.D
Cardiovascular Disease — Payments: $5,621
Cardiovascular Disease $5,621
Dr. Kevin Olsen, M.d, M.D
Cardiovascular Disease — Payments: $4,792
Cardiovascular Disease $4,792
Thomas Dzwonczyk, M.d, M.D
Cardiovascular Disease — Payments: $1,611
Cardiovascular Disease $1,611
Dr. Pranav Karambelkar, Mbbs, MBBS
Cardiovascular Disease — Payments: $1,208
Cardiovascular Disease $1,208
W Fitzpatrick, M.d, M.D
Cardiovascular Disease — Payments: $786.38
Cardiovascular Disease $786.38